Instil Bio, Inc. — Director's Dealing 2021

Mar 25, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Instil Bio, Inc. (TIL)
CIK: 0001789769
Period of Report: 2021-03-23

Reporting Person: Curative Ventures V LLC (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-23	Common Stock	C	30000000	—	Acquired	30000000	Direct
2021-03-23	Common Stock	C	6098799	—	Acquired	36098799	Direct
2021-03-23	Common Stock	C	1431274	—	Acquired	37530073	Direct
2021-03-23	Common Stock	P	450000	$20.00	Acquired	37980073	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-23	Series A Preferred Stock	$	C	25000000	Disposed		Common Stock (30000000)	Direct
2021-03-23	Series B Preferred Stock	$	C	5082333	Disposed		Common Stock (6098799)	Direct
2021-03-23	Series C Preferred Stock	$	C	1192729	Disposed		Common Stock (1431274)	Direct

Footnotes

F1: Each share of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1.2 for one basis, and had no expiration date.